Success Stories: Thanks to an Expedited Service Update, NAmILG Helped an Assistant Professor in the Field of Biostatistics Secure EB1A Approval in just 7 Days without an RFE

Client’s Testimonial:

“Thank you so much! I cannot believe they approved our petition in 7 calendar days including the New Year holiday!”

On January 5^th, 2024, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Biostatistics (Approval Notice).

General Field: Biostatistics

Position at the Time of Case Filing: Assistant Professor

Country of Origin: China

State of Residence at the Time of Filing: Illinois

Approval Notice Date: January 5^th, 2024

Processing Time: 7 days (Premium Processing Requested)

Case Summary:

The USCIS has granted the North America Immigration Law Group‘s I-140 EB1A (Alien of Extraordinary Ability) petition approval for an accomplished assistant professor in the field of biostatistics. The professor’s contributions had a major impact on the entire area, and his accomplishments are extremely valuable because they directly connect to international initiatives aimed at mitigating the effects of gastrointestinal disorders and enhancing mental health services.

As per the regulations of the United States Citizenship and Immigration Services (USCIS), an applicant has to attain the highest level of accomplishment in their respective field to qualify for an EB1A visa. In the present case, the applicant faced no additional difficulties since we were vigilant in reviewing our client’s research background and planned a petition package that was most suited for him.

We convincingly stated that he had dedicated his extraordinary research efforts to the field of biostatistics, focusing on issues related to survival and longitudinal data analysis, biomarker analysis, biomedical research, and machine learning methods, and is regarded as an authority in the field. Furthermore, his work has revolutionized machine learning technology in the advancement of the biomedical field.

Moreover, his extraordinary influence in the field is discussed more specifically below.

We found that he has authored and co-authored 22 peer-reviewed journal articles (8 first-authored and 1 co-first-authored) published in international journals and conference proceedings.
Due to his research’s great applicability in the field, his work in the biostatistics field has been cited 392 times in other peer-reviewed journal articles. Thus, it is obvious that he plays an instrumental role in advancing this research in the United States.
Besides, we affirmed that our client has conducted 15 reviews for highly acclaimed journals to date.
Also, his extraordinary ability in the field is additionally reflected by his current role conducting research at the highly ranked institution, a long-established and widely renowned institution for research with funding from both academic and federal sources.

Furthermore, we bolstered his petition dossier with four recommendation letters that attest to his stellar publication record, academic accomplishments, and proficiency in the field of biostatistics. After looking over our client’s research history, it is clear from his widely recognized publications that he has played a significant role in developing biostatistics research in the United States. He is therefore a priceless asset who needs to carry out his research for the good of the US. Our client was able to obtain the EB1A approval in a mere 7 days, all because of an upgrade to the premium processing service. We truly appreciate his cooperation throughout the process and his faith in our law firm. We hope he succeeds in everything he does in the future.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.